Clover Health CEO Andrew Toy sells $408,260 in stock

Clover Health CEO Andrew Toy relinquished 87,798 shares of the company's Class A Common Stock on August 10, 2026. The sale amounted to around $408,260, with the shares exchanged at prices ranging from $4.61 to $4.65 per share. These transactions were not discretionary trades by Toy. Instead, they were specifically designed to satisfy tax withholding obligations arising from the final vesting of restricted stock units initially granted to Toy on August 8, 2022.

This sale was mandated by Clover Health's equity incentive plans, which require the satisfaction of tax obligations through such transfers.

Toy's share count post-transaction remains at 9,459,316 shares of Clover Health's Class A Common Stock. In a separate development, Clover Health disclosed its financial results for the second quarter of 2026, exceeding Wall Street's projections. The company reported adjusted earnings of 5 cents per share, surpassing the analyst's estimate of 4 cents per share.

Clover Health's revenue for the quarter achieved $743.2 million, outperforming the forecasted $728.27 million. This represents a 56% increase in revenue compared to the same period last year. Moreover, Clover Health has revised its year-end projection, indicating a promising outlook for the remainder of the year. These announcements have drawn the attention of investors and analysts alike.